Sanofi US News

Repeated Doctors Visits, ER Trips, and Admissions to Inpatient/Outpatient Facilities Create High Costs for Managing Patients with a Common, Complex Cardiovascular Disease

-'Diabetes Co-Stars' Offers Information and Support to People Living with Diabetes, Family and Friends -

- Findings Presented at European Association for the Study of Diabetes (EASD) 46th Annual Meeting -

- Phase III Study Results also demonstrated the therapy had acceptable safety profile -

Hundreds of thousands of doses of vaccine and medical supplies also provided

- Funding supports programs to advance personalized medicine -

- 1-vial Taxotere offers simplified preparation -

Early shipments support national goal to increase immunization rates

- Study Findings Presented at American Diabetes Association's 70th Annual Scientific Sessions -

- Study Results Presented at American Diabetes Association's 70th Annual Scientific Sessions -

- First and only therapy to provide significant survival benefit in second-line metastatic hormone-refractory prostate cancer -

- Alliance formed to advance cutting-edge research and foster collaboration between academia and industry -

- Sanofi-aventis Supports Consortium's Activities to Fund Promising Early-Stage Life Sciences Companies -

The licensed technology was developed by the NMRC with the help of the University of Colorado

Interactive Exhibit Unveiled at New Jersey's Liberty Science Center as it Embarks on Three-Year, 12-City Tour

Chattem Becomes the U.S. Consumer Healthcare Platform for sanofi-aventis